HM PAYSON & CO - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 304 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
HM PAYSON & CO ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$12,207
+171.6%
789
+175.9%
0.00%
Q2 2023$4,494
-4.7%
2860.0%0.00%
Q1 2023$4,714
-22.7%
286
-26.9%
0.00%
Q4 2022$6,100
+52.5%
391
+36.7%
0.00%
Q3 2022$4,0000.0%2860.0%0.00%
Q2 2022$4,0000.0%2860.0%0.00%
Q1 2022$4,000
-71.4%
286
-72.3%
0.00%
Q4 2021$14,000
-17.6%
1,0310.0%0.00%
Q3 2021$17,0000.0%1,0310.0%0.00%
Q2 2021$17,000
-10.5%
1,031
-1.0%
0.00%
-100.0%
Q1 2021$19,0000.0%1,0410.0%0.00%0.0%
Q4 2020$19,0000.0%1,0410.0%0.00%0.0%
Q3 2020$19,0000.0%1,0410.0%0.00%0.0%
Q2 2020$19,000
+18.8%
1,0410.0%0.00%0.0%
Q1 2020$16,000
-36.0%
1,041
-19.4%
0.00%0.0%
Q4 2019$25,000
-55.4%
1,292
-60.5%
0.00%
-50.0%
Q3 2019$56,000
-30.0%
3,273
-27.4%
0.00%
-33.3%
Q2 2019$80,0004,5090.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2023
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders